News & Trends - Pharmaceuticals
NSW pharmacists awarded emergency dispensing special authority during COVID-19

Pharma News: The New South Wales Government extended the special authority for emergency supply of medicines without a prescription, in a move that has been welcomed by the Pharmaceutical Society of Australia (PSA).
Patients will be able to receive a maximum PBS quantity or pack size until 30th September 2020 without a prescription, where the pharmacist is satisfied there is immediate need.
The medicine must have been previously prescribed and be for the continuation of current essential treatment where it is impractical to obtain a prescription.
PSA NSW President Professor Peter Carroll said “PSA fully supports and thanks the NSW Government for this very sensible approach which will reduce the concerns of those in the community who may find it hard to access medicines in this challenging environment,” he said.
Register FREE and join 20,000+ industry professionals who receive the latest industry news, innovations and insights from Health Industry Hub; the ONLY one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals.
“This will enable patients to still have ongoing access to their regular medicines in the event that they are not able to see their doctor for a prescription or must self-isolate.
“We are hearing from patients that their GPs are overwhelmed and can be difficult to get an appointment. This flexible approach to healthcare will ensure pharmacists can continue to support the community during the COVID-19 Pandemic.”
“As the peak national body for pharmacists, PSA has called for and worked with the NSW Government to allow the continuation of emergency dispensing that was put in place during the recent bushfire crisis to ensure patients and members of the community continue to gain access to much needed medicines.”
Customer engagement during COVID-19. Health Industry Hub combines expertise in delivering digital health content and measuring engagement with 20+ years industry experience. Created by industry for industry. Contact us.
News & Trends - MedTech & Diagnostics

Medtronic, J&J MedTech and Edwards Lifesciences senior leaders reflect on 2023 and voice outlook for the year ahead
MedTech & Diagnostics News: As we approach the end of 2023, senior leaders in the medtech sector, including Medtronic, Johnson […]
MoreNews & Trends - Pharmaceuticals

Sanofi, AstraZeneca and BeiGene senior leaders reflect on 2023 and voice outlook for the year ahead
Pharma News: As 2023 draws to a close, senior leaders in the pharmaceutical industry paused to reflect on their organisations’ […]
MoreMedical

AbbVie leader takes helm as President of medical affairs association, emphasising optimism fuelled by collaboration
Medical: The Medical Affairs Professionals of Australasia (MAPA) has revealed its newly appointed President and executive committee for 2024. Lauren […]
MoreNews & Trends - MedTech & Diagnostics

National Cabinet endorses hospital funding overhaul as surgery waiting lists skyrocket beyond 850,000
MedTech & Diagnostics News: National Cabinet met in Canberra yesterday to make progress on key health reforms. National Cabinet endorsed […]
More